Education and research information only — not medical advice, and not legal advice. Peptide therapy decisions belong with a licensed physician; legal questions belong with a licensed attorney.
Here is the honest headline: peptide legality in the United States is decided almost entirely at the federal level, by the FDA's drug-approval and compounding rules. What actually varies from state to state is narrower — how you can be prescribed (telehealth rules), where a compounded medication may ship from (pharmacy licensing), and how aggressively state boards enforce. This directory covers all 50 states and DC without inventing differences that don't exist.
Before any state rule matters, a peptide falls into one of three federal categories. No state can move a compound between them.
Category 1 of 3
FDA-approved drugs
Peptide drugs like semaglutide and tirzepatide passed full FDA review. They are legal by prescription in every state — the manufactured, branded products, prescribed and dispensed the ordinary way.
Category 2 of 3
Compounded preparations
State-licensed 503A pharmacies and FDA-registered 503B outsourcing facilities may prepare certain peptides for a specific prescription — but only when the FDA's bulk-substance rules allow that ingredient. This is where nearly all wellness-peptide access lives, and where the FDA has been most active.
Category 3 of 3
“Research use only” chemicals
Peptides sold online with a “not for human consumption” label are not legal products for human use in any state. The FDA began issuing warning letters to RUO peptide sellers in September 2025. No state creates an exception.
The compounding category is the moving part. A short timeline of what the FDA has actually done:
The FDA placed roughly nineteen peptides — including BPC-157, ipamorelin, CJC-1295, AOD-9604, and GHK-Cu — into Category 2 of its interim 503A bulk substances list, citing significant safety risks. Category 2 status effectively ended lawful compounding of these peptides nationwide. Notably, these peptides were never in Category 1 to begin with.
The FDA declared the semaglutide shortage resolved, closing the shortage-era window for compounded copies of GLP-1 drugs. Enforcement followed the calendar: compounded “copies” of approved GLP-1s became largely impermissible for 503A pharmacies and 503B facilities alike.
The FDA issued more than fifty warning letters targeting improper marketing of compounded GLP-1s, “research use only” peptide sales implying human use (BPC-157 among the named products), and the investigational drug retatrutide, which cannot lawfully be compounded at all. An import alert restricted questionable GLP-1 ingredient suppliers.
HHS announced a reversal on many peptides; the FDA then removed roughly fourteen peptides from Category 2 and scheduled formal advisory review. Removal from Category 2 is not approval — it returns a peptide to nominated, pending status.
The Pharmacy Compounding Advisory Committee voted to recommend six peptides — BPC-157, KPV, TB-500, MOTS-c, Epitalon, and Semax — for addition to the 503A bulks list. The vote is advisory; rulemaking was still pending as of September 2026. Five more, including GHK-Cu and Melanotan II, await review, and Melanotan II, GHRP-2, GHRP-6, and LL-37 remain restricted.
One more federal distinction worth knowing: anti-doping status is not law. WADA bans compounds like BPC-157 for competitive athletes as a matter of sport rules, which says nothing about legality for anyone else.
What actually varies by state
Four dimensions genuinely differ across state lines. Everything else you may have read about “peptide-friendly states” is marketing.
1. Telehealth prescribing rules
Most states now allow a physician to establish a valid patient relationship through a real-time telehealth evaluation for non-controlled medications — and most peptides are not controlled substances. A minority of states add requirements: Arkansas bars relationships formed by questionnaire alone, and Alabama requires an in-person visit within twelve months before controlled substances may be prescribed remotely. Federal scrutiny of telehealth platforms that advertise compounded drugs intensified in late 2025.
2. Out-of-state pharmacy licensing
A compounding pharmacy must hold a nonresident pharmacy license in every state it ships into — the shipment itself creates the obligation. Strictness varies widely: California requires its own inspections and charges the nation's highest fees, Florida and Texas demand recent specialized inspections for sterile compounders, while Virginia and Louisiana accept national (NABP) inspection programs. Practically, this decides which pharmacies can legally serve your state.
3. Board enforcement posture
The rules may match, but the policing doesn't. Ohio has summarily suspended more than thirty clinics and med spas since early 2025; Washington issued a stop-service order against a GLP-1 compounder in March 2025; Connecticut, Illinois, and South Carolina route enforcement through attorneys general and consumer-protection law instead of the pharmacy board.
4. State-specific compounding action
A handful of states have gone beyond the federal floor — California is the only one to do so with the force of law (October 2025 regulations), while roughly a dozen boards have issued GLP-1 or semaglutide position statements. No state has enacted a statute specifically legalizing or banning wellness peptides like BPC-157; that question lives entirely with the FDA.
The 50-state directory (plus DC)
Each entry covers the three dimensions that matter. Where our research verified a state-specific action, the entry says so and is marked Verified state action. Where a state has not meaningfully diverged from the federal baseline, we say that plainly — an honest “standard rules” entry beats an invented one. This directory is educational information, not legal advice.
Entries reflect research as of September 2026. Rules change; verify anything decision-critical with your state's medical board, pharmacy board, or a licensed attorney.
Alabama Verified state action
Telehealth prescribing
Alabama requires an in-person encounter within the preceding 12 months before controlled substances may be prescribed via telehealth; most peptides are not controlled substances, so this mainly matters if therapy is combined with controlled medications.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
The Alabama Board of Medical Examiners issued declaratory rulings in August 2024 addressing physician and physician-office compounding — relevant to clinics that prepare compounded medications on site.
Alaska Verified state action
Telehealth prescribing
Alaska permits establishing the patient–physician relationship by telehealth for non-controlled prescriptions, provided follow-up care is available through the practice.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
No peptide-specific action by this state's legislature, medical board, or pharmacy board identified as of September 2026. The federal FDA compounding framework is the operative constraint here.
Arizona Verified state action
Telehealth prescribing
Arizona allows a telehealth encounter to serve as the required examination when it is appropriate for the patient and the condition, so telehealth-initiated prescribing of non-controlled medications is generally available.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
No peptide-specific action by this state's legislature, medical board, or pharmacy board identified as of September 2026. The federal FDA compounding framework is the operative constraint here.
Arkansas Verified state action
Telehealth prescribing
Arkansas prohibits forming a patient–physician relationship through an internet questionnaire, email, text, or fax alone; a real-time audio-video telehealth evaluation can satisfy the requirement.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
No peptide-specific action by this state's legislature, medical board, or pharmacy board identified as of September 2026. The federal FDA compounding framework is the operative constraint here.
California Verified state action
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Among the strictest ship-to states: California requires its own inspection of nonresident pharmacies (Bus. & Prof. Code § 4127.2 for sterile compounders) and charges some of the highest licensure fees in the country.
State-specific note
Effective October 1, 2025, California comprehensively rewrote its compounding regulations (16 CCR §§ 1735 et seq.): pharmacists must verify and document a clinically significant, patient-specific difference before compounding a version of an FDA-approved drug, and certificates of analysis must identify the actual ingredient manufacturer. California is currently the only state with GLP-1-relevant compounding requirements carrying the force of law beyond the federal floor.
Colorado Standard rules
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
No peptide-specific action by this state's legislature, medical board, or pharmacy board identified as of September 2026. The federal FDA compounding framework is the operative constraint here.
Connecticut Verified state action
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
In May 2025 the Connecticut Attorney General sued a GLP-1 weight-loss drug distributor under the state's unfair trade practices statute — an example of enforcement arriving through consumer-protection law rather than the pharmacy board.
Delaware Standard rules
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
No peptide-specific action by this state's legislature, medical board, or pharmacy board identified as of September 2026. The federal FDA compounding framework is the operative constraint here.
District of Columbia Standard rules
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
No peptide-specific action by this state's legislature, medical board, or pharmacy board identified as of September 2026. The federal FDA compounding framework is the operative constraint here.
Florida Verified state action
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Florida's nonresident sterile-compounding permit requires a recent inspection (within six months for initial applications, one year for renewals) and does not accept NABP Verified Pharmacy Program inspections — only home-state regulator or FDA inspections.
State-specific note
Florida's sterile compounding rule expressly ties state standards to Section 503A of the federal FD&C Act (adopted November 2023, effective February 2, 2025), so Florida's position on any given peptide tracks the FDA's position.
Georgia Standard rules
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
No peptide-specific action by this state's legislature, medical board, or pharmacy board identified as of September 2026. The federal FDA compounding framework is the operative constraint here.
Hawaii Standard rules
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
No peptide-specific action by this state's legislature, medical board, or pharmacy board identified as of September 2026. The federal FDA compounding framework is the operative constraint here.
Idaho Standard rules
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
No peptide-specific action by this state's legislature, medical board, or pharmacy board identified as of September 2026. The federal FDA compounding framework is the operative constraint here.
Illinois Verified state action
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
Illinois issued a consumer alert in January 2025 warning residents about compounded GLP-1 drugs — an advisory posture rather than a new binding rule.
Indiana Standard rules
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
No peptide-specific action by this state's legislature, medical board, or pharmacy board identified as of September 2026. The federal FDA compounding framework is the operative constraint here.
Iowa Standard rules
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
No peptide-specific action by this state's legislature, medical board, or pharmacy board identified as of September 2026. The federal FDA compounding framework is the operative constraint here.
Kansas Verified state action
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
The Kansas Board of Pharmacy issued a statement on compounded semaglutide in April 2024, largely restating the federal framework.
Kentucky Verified state action
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
The Kentucky Board of Pharmacy issued GLP-1 compounding guidance in 2025, largely restating federal requirements for state licensees.
Louisiana Verified state action
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Louisiana accepts NABP Verified Pharmacy Program inspections for nonresident pharmacy licensure. Separately, the Board of Pharmacy has directed out-of-state pharmacies not to ship compounded semaglutide salt forms to Louisiana residents.
State-specific note
The Louisiana Board of Pharmacy was an early mover on compounded semaglutide (2023), instructing in-state pharmacies to stop compounding salt forms of the drug and out-of-state pharmacies to stop shipping them into Louisiana.
Maine Standard rules
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
No peptide-specific action by this state's legislature, medical board, or pharmacy board identified as of September 2026. The federal FDA compounding framework is the operative constraint here.
Maryland Standard rules
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
No peptide-specific action by this state's legislature, medical board, or pharmacy board identified as of September 2026. The federal FDA compounding framework is the operative constraint here.
Massachusetts Verified state action
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Massachusetts implemented a long-awaited licensing regime for out-of-state pharmacies, ending its historical status as one of the few states without nonresident pharmacy licensure. Out-of-state compounders shipping into Massachusetts now need a Massachusetts license.
State-specific note
No peptide-specific action by this state's legislature, medical board, or pharmacy board identified as of September 2026. The federal FDA compounding framework is the operative constraint here.
Michigan Standard rules
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
No peptide-specific action by this state's legislature, medical board, or pharmacy board identified as of September 2026. The federal FDA compounding framework is the operative constraint here.
Minnesota Standard rules
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
No peptide-specific action by this state's legislature, medical board, or pharmacy board identified as of September 2026. The federal FDA compounding framework is the operative constraint here.
Mississippi Standard rules
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
No peptide-specific action by this state's legislature, medical board, or pharmacy board identified as of September 2026. The federal FDA compounding framework is the operative constraint here.
Missouri Standard rules
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
No peptide-specific action by this state's legislature, medical board, or pharmacy board identified as of September 2026. The federal FDA compounding framework is the operative constraint here.
Montana Standard rules
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
No peptide-specific action by this state's legislature, medical board, or pharmacy board identified as of September 2026. The federal FDA compounding framework is the operative constraint here.
Nebraska Standard rules
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
No peptide-specific action by this state's legislature, medical board, or pharmacy board identified as of September 2026. The federal FDA compounding framework is the operative constraint here.
Nevada Standard rules
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
No peptide-specific action by this state's legislature, medical board, or pharmacy board identified as of September 2026. The federal FDA compounding framework is the operative constraint here.
New Hampshire Standard rules
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
No peptide-specific action by this state's legislature, medical board, or pharmacy board identified as of September 2026. The federal FDA compounding framework is the operative constraint here.
New Jersey Verified state action
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
The New Jersey Board of Pharmacy issued a position statement on semaglutide compounding in November 2023: no salt forms, and active ingredients must be pharmaceutical grade from FDA-registered sources with valid certificates of analysis.
New Mexico Standard rules
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
No peptide-specific action by this state's legislature, medical board, or pharmacy board identified as of September 2026. The federal FDA compounding framework is the operative constraint here.
New York Standard rules
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
No peptide-specific action by this state's legislature, medical board, or pharmacy board identified as of September 2026. The federal FDA compounding framework is the operative constraint here.
North Carolina Standard rules
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
No peptide-specific action by this state's legislature, medical board, or pharmacy board identified as of September 2026. The federal FDA compounding framework is the operative constraint here.
North Dakota Standard rules
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
No peptide-specific action by this state's legislature, medical board, or pharmacy board identified as of September 2026. The federal FDA compounding framework is the operative constraint here.
Ohio Verified state action
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Ohio requires active pharmaceutical ingredients used in compounding to be sourced from an Ohio-licensed distributor — a supply-chain rule that reaches pharmacies shipping into the state.
State-specific note
One of the most active enforcement states. In July 2025 the Ohio Board of Pharmacy issued GLP-1-specific guidance treating semaglutide and tirzepatide as no longer compoundable after the shortage ended, and expressly prohibited compounding the investigational peptides retatrutide and cagrilintide. Ohio regulators have summarily suspended more than thirty clinics and medical spas since early 2025.
Oklahoma Standard rules
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
No peptide-specific action by this state's legislature, medical board, or pharmacy board identified as of September 2026. The federal FDA compounding framework is the operative constraint here.
Oregon Verified state action
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
The Oregon Board of Pharmacy issued a position statement on compounded semaglutide in February 2025, largely restating the federal framework.
Pennsylvania Standard rules
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
No peptide-specific action by this state's legislature, medical board, or pharmacy board identified as of September 2026. The federal FDA compounding framework is the operative constraint here.
Rhode Island Standard rules
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
No peptide-specific action by this state's legislature, medical board, or pharmacy board identified as of September 2026. The federal FDA compounding framework is the operative constraint here.
South Carolina Verified state action
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
The South Carolina Attorney General issued a consumer alert in January 2025 about compounded weight-loss medications — advisory, consumer-protection-level action.
South Dakota Standard rules
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
No peptide-specific action by this state's legislature, medical board, or pharmacy board identified as of September 2026. The federal FDA compounding framework is the operative constraint here.
Tennessee Standard rules
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
No peptide-specific action by this state's legislature, medical board, or pharmacy board identified as of September 2026. The federal FDA compounding framework is the operative constraint here.
Texas Verified state action
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Texas nonresident (Class E) pharmacy licenses require an inspection dated within the last three years; sterile-compounding (Class E-S) licenses require a current-renewal-period inspection by an approved inspection body (ACHC, NABP, or Superior Laboratory Services).
State-specific note
Texas boards have issued no peptide- or GLP-1-specific position; the state regulates through its general compounding framework, which already incorporates the federal “essentially a copy” limitation.
Utah Standard rules
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
No peptide-specific action by this state's legislature, medical board, or pharmacy board identified as of September 2026. The federal FDA compounding framework is the operative constraint here.
Vermont Standard rules
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
No peptide-specific action by this state's legislature, medical board, or pharmacy board identified as of September 2026. The federal FDA compounding framework is the operative constraint here.
Virginia Verified state action
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Virginia accepts NABP Verified Pharmacy Program inspections in place of its own for nonresident pharmacy licensure (since 2013), making it one of the more streamlined ship-to states.
State-specific note
No peptide-specific action by this state's legislature, medical board, or pharmacy board identified as of September 2026. The federal FDA compounding framework is the operative constraint here.
Washington Verified state action
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
An enforcement-forward state: the Pharmacy Quality Assurance Commission issued a semaglutide statement in August 2024 and imposed a stop-service order on a GLP-1 sterile compounder in March 2025 for compliance failures.
West Virginia Verified state action
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
The West Virginia Board of Pharmacy issued one of the earliest state statements on compounded semaglutide, in April 2023.
Wisconsin Standard rules
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
No peptide-specific action by this state's legislature, medical board, or pharmacy board identified as of September 2026. The federal FDA compounding framework is the operative constraint here.
Wyoming Standard rules
Telehealth prescribing
We did not identify a telehealth prescribing rule stricter than the national norm for non-controlled medications. Like most states, a patient–physician relationship can generally be established through a real-time telehealth evaluation, subject to the state medical board's standard-of-care rules.
Compounded shipping
Standard rule: an out-of-state pharmacy must hold this state's nonresident pharmacy license or registration before shipping compounded prescriptions to patients here.
State-specific note
No peptide-specific action by this state's legislature, medical board, or pharmacy board identified as of September 2026. The federal FDA compounding framework is the operative constraint here.
Questions to ask in your state
The directory tells you the landscape. These questions — put to a licensed physician or pharmacist in your state — get you the current, local answer.
For a physician: “Is this peptide currently eligible for compounding under the FDA's 503A bulk substances rules, or is it FDA-approved?” If it's neither, no state makes it prescribable.
For a physician: “Can you evaluate me by telehealth under this state's rules, or does anything about my situation require an in-person visit?”
For a pharmacy: “Do you hold a nonresident pharmacy license for my state?” A legitimate pharmacy answers instantly; hesitation is your answer.
For a pharmacy: “Are you a state-licensed 503A pharmacy or an FDA-registered 503B outsourcing facility?” Anything that is neither is not a pharmacy.
For either: “Has this state's board issued guidance on this compound?” — particularly for GLP-1s, where about a dozen states have.
Frequently asked questions
Is BPC-157 legal in my state?
BPC-157's status is set federally, not state by state. It is not an FDA-approved drug anywhere in the United States. From 2023 to early 2026 the FDA classified it as a Category 2 bulk substance (“significant safety risk”), which kept it out of legal 503A compounding nationwide. In 2026 the FDA removed BPC-157 from Category 2, and in July 2026 the Pharmacy Compounding Advisory Committee voted to recommend adding it to the 503A bulk substances list — but that recommendation is advisory, and formal rulemaking had not been completed as of September 2026. No state has made BPC-157 “legal” on its own; a licensed physician in your state is the right person to ask what can currently be prescribed.
Can I get peptides prescribed through telehealth?
In most states, yes in principle: a patient–physician relationship for non-controlled medications can generally be established through a real-time telehealth evaluation. What a physician may actually prescribe is limited by the federal rules — only FDA-approved products or lawfully compounded preparations qualify, and in September 2025 federal regulators began actively targeting telehealth platforms that advertised compounded drugs improperly. A few states add friction, such as Arkansas's bar on questionnaire-only prescribing. The dependable path is a real evaluation by a physician licensed in your state.
Why do compounding pharmacies matter for peptide access?
Most peptides discussed in wellness settings are not FDA-approved drugs, so the only lawful way they can ever reach a patient is as a compounded preparation — made by a state-licensed 503A pharmacy for a specific patient's prescription, or by an FDA-registered 503B outsourcing facility — and only when the FDA's bulk-substance rules permit that ingredient at all. That is why the FDA's category decisions, not state statutes, decide which peptides a pharmacy anywhere in the country may compound.
Did the FDA ban peptides in 2023?
Not exactly, but the practical effect was close for certain compounds. In late 2023 the FDA placed roughly nineteen peptides — including BPC-157, ipamorelin, and CJC-1295 — into Category 2 of its interim 503A bulk substances list, flagging significant safety risks and effectively ending lawful compounding of them. In 2026 the agency reversed course on many: about fourteen were removed from Category 2 following a February 2026 HHS announcement, and an advisory committee voted in July 2026 to recommend six (BPC-157, KPV, TB-500, MOTS-c, Epitalon, and Semax) for the compounding list. Others — including Melanotan II, GHRP-2, GHRP-6, and LL-37 — remained restricted as of September 2026.
Are “research use only” peptides legal to buy?
“Research use only” peptides are not legal products for human use in any state. The label means the substance is not manufactured, tested, or approved for people — and the FDA treats selling an RUO-labeled peptide while implying human use as a violation, a theory it acted on with a wave of warning letters beginning in September 2025 that named products including BPC-157 and the investigational drug retatrutide. No state law changes this. If a peptide therapy is worth pursuing, it is worth pursuing through a licensed physician and a licensed pharmacy.
This is not legal advice
This directory is educational — it maps the regulatory landscape so you can ask better questions. It is not legal advice, it is not medical advice, and it cannot substitute for either. Regulations cited here change; several changed while this page was being researched. For a legal question, consult a licensed attorney in your state. For whether any peptide therapy is appropriate and lawfully available for you, there is exactly one right path: a licensed physician who can evaluate you, prescribe when justified, and route any prescription through a licensed pharmacy.